Tom Groot Kormelink

470 total citations
12 papers, 352 citations indexed

About

Tom Groot Kormelink is a scholar working on Immunology, Physiology and Immunology and Allergy. According to data from OpenAlex, Tom Groot Kormelink has authored 12 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Physiology and 4 papers in Immunology and Allergy. Recurrent topics in Tom Groot Kormelink's work include Mast cells and histamine (6 papers), Asthma and respiratory diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Tom Groot Kormelink is often cited by papers focused on Mast cells and histamine (6 papers), Asthma and respiratory diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Tom Groot Kormelink collaborates with scholars based in Netherlands, Mexico and Germany. Tom Groot Kormelink's co-authors include Frank A. Redegeld, Bart R. Blokhuis, Marco Thio, Esther C. de Jong, Johan Garssen, J. W. J. Bijlsma, Rogier M. Thurlings, Janneke Tekstra, Koen Vos and F.P. Lafeber and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Tom Groot Kormelink

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Groot Kormelink Netherlands 11 163 91 75 71 61 12 352
Yehong Wang China 10 107 0.7× 102 1.1× 69 0.9× 60 0.8× 31 0.5× 25 385
Fumiko Suenaga Japan 7 210 1.3× 123 1.4× 57 0.8× 78 1.1× 33 0.5× 8 477
Luc Colas France 9 117 0.7× 73 0.8× 92 1.2× 62 0.9× 29 0.5× 19 297
Samuel Goldman United States 10 108 0.7× 74 0.8× 94 1.3× 15 0.2× 60 1.0× 32 399
Rafael Marino Canada 7 123 0.8× 101 1.1× 54 0.7× 28 0.4× 47 0.8× 11 369
E Tanabe Japan 10 259 1.6× 214 2.4× 65 0.9× 39 0.5× 18 0.3× 20 460
Lesley Woods United States 7 106 0.7× 149 1.6× 41 0.5× 55 0.8× 27 0.4× 9 285
I Pawlowski United States 9 98 0.6× 85 0.9× 53 0.7× 46 0.6× 106 1.7× 10 391
J C Guérin France 9 66 0.4× 83 0.9× 27 0.4× 118 1.7× 198 3.2× 32 425
Nancy Carteron United States 7 161 1.0× 117 1.3× 35 0.5× 11 0.2× 29 0.5× 10 358

Countries citing papers authored by Tom Groot Kormelink

Since Specialization
Citations

This map shows the geographic impact of Tom Groot Kormelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Groot Kormelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Groot Kormelink more than expected).

Fields of papers citing papers by Tom Groot Kormelink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Groot Kormelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Groot Kormelink. The network helps show where Tom Groot Kormelink may publish in the future.

Co-authorship network of co-authors of Tom Groot Kormelink

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Groot Kormelink. A scholar is included among the top collaborators of Tom Groot Kormelink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Groot Kormelink. Tom Groot Kormelink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Voskamp, Astrid, Tamar Tak, Roberta Menafra, et al.. (2023). Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge. The Journal of Experimental Medicine. 220(9). 4 indexed citations
2.
Hafkamp, Florianne, Tom Groot Kormelink, & Esther C. de Jong. (2021). Targeting DCs for Tolerance Induction: Don’t Lose Sight of the Neutrophils. Frontiers in Immunology. 12. 732992–732992. 16 indexed citations
3.
Voskamp, Astrid, Tom Groot Kormelink, Roy Gerth van Wijk, et al.. (2020). Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies. Seminars in Immunopathology. 42(1). 95–110. 16 indexed citations
4.
Kormelink, Tom Groot, Desmond G. Powe, Marcel H.A.M. Fens, et al.. (2014). Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation. Oncotarget. 5(10). 3159–3167. 33 indexed citations
5.
Kormelink, Tom Groot, Lien Calus, Natalie De Ruyck, et al.. (2012). Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps. Allergy. 67(9). 1165–1172. 17 indexed citations
6.
Braber, Saskia, Marco Thio, Bart R. Blokhuis, et al.. (2012). An Association between Neutrophils and Immunoglobulin Free Light Chains in the Pathogenesis of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 185(8). 817–824. 46 indexed citations
7.
Kormelink, Tom Groot, Philip W. Askenase, & Frank A. Redegeld. (2012). Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases. Current Pharmaceutical Design. 18(16). 2278–2289. 10 indexed citations
8.
Thio, Marco, Tom Groot Kormelink, Marcel J.E. Fischer, et al.. (2012). Antigen Binding Characteristics of Immunoglobulin Free Light Chains: Crosslinking by Antigen is Essential to Induce Allergic Inflammation. PLoS ONE. 7(7). e40986–e40986. 19 indexed citations
9.
Kormelink, Tom Groot, Annie Pardo, Karen Knipping, et al.. (2011). Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. PLoS ONE. 6(9). e25392–e25392. 39 indexed citations
10.
Schouten, Bastiaan, Betty C. A. M. van Esch, Tom Groot Kormelink, et al.. (2011). Non‐digestible oligosaccharides reduce immunoglobulin free light‐chain concentrations in infants at risk for allergy. Pediatric Allergy and Immunology. 22(5). 537–542. 35 indexed citations
11.
Kormelink, Tom Groot, Janneke Tekstra, Rogier M. Thurlings, et al.. (2010). Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Annals of the Rheumatic Diseases. 69(12). 2137–2144. 59 indexed citations
12.
Kormelink, Tom Groot, et al.. (2009). Mast Cells as Target in Cancer Therapy. Current Pharmaceutical Design. 15(16). 1868–1878. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yehong Wang Breakdown of academic impact, for papers by Fumiko Suenaga Breakdown of academic impact, for papers by Luc Colas Breakdown of academic impact, for papers by Samuel Goldman Breakdown of academic impact, for papers by Rafael Marino Breakdown of academic impact, for papers by E Tanabe Breakdown of academic impact, for papers by Lesley Woods Breakdown of academic impact, for papers by I Pawlowski Breakdown of academic impact, for papers by J C Guérin Breakdown of academic impact, for papers by Nancy Carteron
Rankless by CCL
2026